ELOVL4 Polyclonal Antibody

ELOVL4 encodes a membrane-bound protein which is a member of the ELO family, proteins which participate in the biosynthesis of fatty acids. Consistent with the expression of the encoded protein in photoreceptor cells of the retina, mutations and small deletions in ELOVL4 are associated with Stargardt-like macular dystrophy (STGD3) and autosomal dominant Stargardt-like macular dystrophy (ADMD), also referred to as autosomal dominant atrophic macular degeneration.

The ELOVL4 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of ELOVL4 protein expression in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional sensitivity and specificity.

The ELOVL4 Polyclonal Antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the ELOVL4 protein. It has been extensively validated for its ability to recognize endogenous levels of ELOVL4 in a variety of species, including human, mouse, and rat.

This antibody exhibits excellent performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It enables researchers to accurately assess the expression and localization of ELOVL4 in different tissues and cell types.

The ELOVL4 Polyclonal Antibody offers numerous advantages, including high specificity, low background, and robust signal intensity. It is manufactured under strict quality control standards to ensure batch-to-batch consistency and reproducibility.

With its exceptional performance and reliability, the ELOVL4 Polyclonal Antibody is an indispensable tool for researchers studying the role of ELOVL4 in various biological processes, such as lipid metabolism, retinal degeneration, and neurodevelopmental disorders.